Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Lactate dyscrasia: a novel explanation for amyotrophic lateral sclerosis.

Vadakkadath Meethal S, Atwood CS.

Neurobiol Aging. 2012 Mar;33(3):569-81. doi: 10.1016/j.neurobiolaging.2010.04.012. Epub 2010 Jun 11. Review.

PMID:
20541840
2.

Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis.

Martin LJ.

J Neuropathol Exp Neurol. 2006 Dec;65(12):1103-10. Review.

PMID:
17146283
3.
4.

Translational therapeutic strategies in amyotrophic lateral sclerosis.

Ryu H, Ferrante RJ.

Mini Rev Med Chem. 2007 Feb;7(2):141-50. Review.

PMID:
17305588
5.

Lactate stress testing in sporadic amyotrophic lateral sclerosis.

Finsterer J.

Int J Neurosci. 2005 Apr;115(4):583-91.

PMID:
15809220
6.

A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.

Franz CK, Quach ET, Krudy CA, Federici T, Kliem MA, Snyder BR, Raore B, Boulis NM.

PLoS One. 2009 Oct 6;4(10):e7357. doi: 10.1371/journal.pone.0007357.

7.

Amyotrophic lateral sclerosis: Lou Gehrig's disease.

Walling AD.

Am Fam Physician. 1999 Mar 15;59(6):1489-96. Review.

8.

Physical activity and neuroprotection in amyotrophic lateral sclerosis.

McCrate ME, Kaspar BK.

Neuromolecular Med. 2008;10(2):108-17. doi: 10.1007/s12017-008-8030-5. Epub 2008 Feb 20. Review.

PMID:
18286388
9.

Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals.

CarrĂ­ MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G.

Brain Res Bull. 2003 Aug 30;61(4):365-74. Review.

PMID:
12909279
10.

Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?

Sreedharan J.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):259-67. Review.

PMID:
20406185
11.

Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.

Zhou J, Yi J, Bonewald L.

Curr Osteoporos Rep. 2015 Oct;13(5):274-9. doi: 10.1007/s11914-015-0281-0. Review.

PMID:
26223903
12.

The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis.

Pasquali L, Ruffoli R, Fulceri F, Pietracupa S, Siciliano G, Paparelli A, Fornai F.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):268-78. Review.

PMID:
20406184
13.
14.

Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.

Carlesi C, Pasquali L, Piazza S, Lo Gerfo A, Caldarazzo Ienco E, Alessi R, Fornai F, Siciliano G.

Arch Ital Biol. 2011 Mar;149(1):151-67. doi: 10.4449/aib.v149i1.1267. Review.

PMID:
21412722
15.

Excitotoxicity and amyotrophic lateral sclerosis.

Van Damme P, Dewil M, Robberecht W, Van Den Bosch L.

Neurodegener Dis. 2005;2(3-4):147-59. Review.

PMID:
16909020
16.

Amyotrophic lateral sclerosis from bench to bedside.

Lomen-Hoerth C.

Semin Neurol. 2008 Apr;28(2):205-11. doi: 10.1055/s-2008-1062265. Review.

PMID:
18351522
17.

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S.

BMC Genomics. 2007 Jan 23;8:26.

18.
19.

Specific electron transport chain abnormalities in amyotrophic lateral sclerosis.

Lin J, Diamanduros A, Chowdhury SA, Scelsa S, Latov N, Sadiq SA.

J Neurol. 2009 May;256(5):774-82. doi: 10.1007/s00415-009-5015-8. Epub 2009 Feb 25.

PMID:
19240958
20.

Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.

Yoo YE, Ko CP.

Exp Neurol. 2011 Sep;231(1):147-59. doi: 10.1016/j.expneurol.2011.06.003. Epub 2011 Jun 25.

PMID:
21712032

Supplemental Content

Support Center